Catalyst combining reactivity, selectivity could speed drug development

15 octubre 2015

Chemists have long believed that inserting nitrogen — a beneficial ingredient for making many pharmaceuticals and other biologically active molecules — into a carbon-hydrogen bond requires a trade-off between catalyst reactivity and selectivity. But a new manganese-based catalyst has given researchers both in one efficient, lower-cost package.